['hepatitis c']
['daclatasvir', 'sofosbuvir', 'ribavirin']

        For more information regarding BMS clinical trial participation, please visit
        www.BMSStudyConnect.com

        Inclusion Criteria:

          -  Must have Genotype 3 Chronic HCV

          -  Must have advanced fibrosis (F3) or compensated cirrhosis (F4)

          -  HCV RNA Viral load ≥ 10,000 IU/mL

          -  HCV Treatment naive or treatment-experienced

        Exclusion Criteria:

          -  Non Genotype 3 or mixed genotypes

          -  Non advanced fibrosis or compensated cirrhosis

          -  Any prior treatment with NS5A inhibitors
      